5
views
0
recommends
+1 Recommend
2 collections
    0
    shares

      To learn more about AK Journals, please click here

      The APC waiver has been extended to also apply to manuscripts submitted until March 31, 2024.

      To submit to the journal, please click here.

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Antifungal potential, mechanism of action, and toxicity of 1,4-naphthoquinone derivatives

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The rising prevalence of fungal infections and challenges such as adverse effects and resistance against existing antifungal agents have driven the exploration of new antifungal substances.

          Methods

          We specifically investigated naphthoquinones, known for their broad biological activities and promising antifungal capabilities. It specifically examined the effects of a particular naphthoquinone on the cellular components of Candida albicans ATCC 60193. The study also assessed cytotoxicity in MRC-5 cells, Artemia salina, and the seeds of tomatoes and arugula.

          Results

          Among four tested naphthoquinones, 2,3-DBNQ (2,3-dibromonaphthalene-1,4-dione) was identified as highly effective, showing potent antifungal activity at concentrations between 1.56 and 6.25 μg mL −1. However, its cytotoxicity in MRC-5 cells (IC 50 = 15.44 µM), complete mortality in A. salina at 50 μg mL −1, and significant seed germination inhibition suggest limitations for its clinical use.

          Conclusions

          The findings indicate that primary antifungal mechanism of 2,3-DBNQ might involve disrupting fungal membrane permeability, which leads to increased nucleotide leakage. This insight underscores the need for further research to enhance the selectivity and safety of naphthoquinones for potential therapeutic applications.

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay.

          A one-step non-radioactive assay to determine the proliferation of murine lymphocytes, lymphoid tumor cells and hybridoma cells is described. This assay requires the addition of Alamar Blue dye to cell cultures and the degree of change in its color, which is reflective of the extent of cellular proliferation, can be determined by an ELISA plate reader. Alamar Blue must be added during the initial phase of cell culture. The pattern of concanavalin A (ConA) or anti-CD3 antibody-induced proliferative response of murine lymphocytes as assessed by Alamar Blue was similar to that of a [3H]thymidine assay. Similarly, the spontaneous proliferation curve of anti-CD3 antibody secreting cell line (YCD3-1), monocytic macrophage cell lines (PU5-1.8, P388D1, J774.1) and myeloma cells (Sp2/0) as determined by Alamar Blue closely resembled that of the [3H]thymidine assay. The minimum detectable number of proliferating cells was comparable in Alamar Blue and [3H]thymidine assays. Since cell lysis/extraction and washing procedures are not involved in the Alamar Blue assay, this approach has several distinct advantages over currently available assays (eg. [3H]thymidine). First, it allows daily monitoring of proliferation without compromising the sterility of cultures. An indication of proliferation can be evaluated (spectrophotometrically or visually) as early as 24 h after ConA stimulation. Second, unlike previously reported assays, Alamar Blue permits further analysis of proliferating cells by other methods. Analysis of cells in culture with Alamar Blue for various surface antigens (CD44, CD45RB, CD4, heat stable antigen) by flow cytometry revealed that the fluorescent profile and relative percentage of cells in cultures with the Alamar Blue were comparable to those without this reagent. The salient advantages of Alamar Blue assay over the [3H]thymidine assay include: (i) non-radioactivity; (ii) simplicity; (iii) less costly; (iv) non-labor intensive; (v) rapidity of assessment of proliferation of large number of samples; (vi) non-toxicity; (vii) usefulness in determining the kinetics of cell growth of hybridomas; and (viii) non-interference of secretion of antibodies by a hybridoma cell line.
            • Record: found
            • Abstract: found
            • Article: not found

            A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.

            Candida auris has emerged globally as an MDR nosocomial pathogen in ICU patients.
              • Record: found
              • Abstract: found
              • Article: not found

              Candida auris: The recent emergence of a multidrug-resistant fungal pathogen

              Candida auris is an emerging multidrug-resistant yeast that causes serious invasive infections with high mortality. It was first discovered in 2009, and since then, individual cases or outbreaks have been reported from over 20 countries on five continents. Controlling C. auris is challenging for several reasons: (1) it is resistant to multiple classes of antifungals, (2) it can be misidentified as other yeasts by commonly available identification methods, and (3) because of its ability to colonize patients perhaps indefinitely and persist in the healthcare environment, it can spread between patients in healthcare settings. The transmissibility and high levels of antifungal resistance that are characteristic of C. auris set it apart from most other Candida species. A robust response that involves the laboratory, clinicians, and public health agencies is needed to identify and treat infections and prevent transmission. We review the global emergence, biology, challenges with laboratory identification, drug resistance, clinical manifestations, treatment, risk factors for infection, transmission, and control of C. auris.

                Author and article information

                Contributors
                Journal
                Eur J Microbiol Immunol (Bp)
                Eur J Microbiol Immunol (Bp)
                EUJMI
                European Journal of Microbiology & Immunology
                Akadémiai Kiadó (Budapest )
                2062-509X
                2062-8633
                23 August 2024
                September 2024
                : 14
                : 3
                : 289-295
                Affiliations
                [1 ]Postgraduate Program in Biotechnology and Natural Resources of the Amazon, Higher School of Health Sciences, Amazonas State University (UEA) , Manaus, Amazonas, Brazil
                [2 ]Mycology Laboratory, National Institute for Amazonian Research (INPA) , Manaus, Amazonas, Brazil
                [3 ]Faculty of Pharmaceutical Sciences, Federal University of Amazonas (UFAM) , Manaus, Amazonas, Brazil
                [4 ]Collection of Microorganisms of Medical Interest, National Institute for Amazonian Research (INPA) , Manaus, Amazonas, Brazil
                [5 ]Higher School of Technology, Amazonas State University (UEA) , Manaus, Amazonas, Brazil
                [6 ]Institute for Medical Microbiology, Virology and Hygiene, University Medicine Rostock , Rostock, Germany
                [7 ]Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital , Germany
                Author notes
                [* ]Corresponding author. Mycology Laboratory. National Institute for Amazonian Research , Av. André Araújo, 2936 – Petrópolis, CEP: 69060-001, Manaus, Amazonas, Brazil. Tel.: +55 (92) 3643 3055/3056. E-mail: joaovicentebragasouza@ 123456yahoo.com.br
                Author information
                https://orcid.org/0000-0002-3163-7499
                Article
                10.1556/1886.2024.00072
                11393642
                39178045
                d0a246f6-9ab4-4669-9dec-a051f41ae976
                © 2024 The Author(s)

                Open Access statement. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium for non-commercial purposes, provided the original author and source are credited, a link to the CC License is provided, and changes – if any – are indicated.

                History
                : 20 June 2024
                : 06 August 2024
                Page count
                Figures: 3, Tables: 2, Equations: 2, References: 26, Pages: 00
                Funding
                Funded by: Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM)
                Funded by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES)
                Categories
                Article

                antifungal potential,naphthoquinone derivatives,2,3-dbnq,fungal membrane permeability,cytotoxicity

                Comments

                Comment on this article

                Related Documents Log